176 related articles for article (PubMed ID: 31591165)
1. Construction and Characterization of the Mycobacterium tuberculosis
Hernandez-Pando R; Shin SJ; Clark S; Casonato S; Becerril-Zambrano M; Kim H; Boldrin F; Mata-Espinoza D; Provvedi R; Arbues A; Marquina-Castillo B; Cioetto Mazzabò L; Barrios-Payan J; Martin C; Cho SN; Williams A; Manganelli R
Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31591165
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis sigE mutant ST28 used as a vaccine induces protective immunity in the guinea pig model.
Troudt J; Creissen E; Izzo L; Bielefeldt-Ohmann H; Casonato S; Manganelli R; Izzo AA
Tuberculosis (Edinb); 2017 Sep; 106():99-105. PubMed ID: 28802412
[TBL] [Abstract][Full Text] [Related]
3. Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.
Arbues A; Aguilo JI; Gonzalo-Asensio J; Marinova D; Uranga S; Puentes E; Fernandez C; Parra A; Cardona PJ; Vilaplana C; Ausina V; Williams A; Clark S; Malaga W; Guilhot C; Gicquel B; Martin C
Vaccine; 2013 Oct; 31(42):4867-73. PubMed ID: 23965219
[TBL] [Abstract][Full Text] [Related]
4. Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential.
Pérez I; Uranga S; Sayes F; Frigui W; Samper S; Arbués A; Aguiló N; Brosch R; Martín C; Gonzalo-Asensio J
EBioMedicine; 2020 May; 55():102761. PubMed ID: 32361249
[TBL] [Abstract][Full Text] [Related]
5. Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant.
Senaratne RH; Mougous JD; Reader JR; Williams SJ; Zhang T; Bertozzi CR; Riley LW
J Med Microbiol; 2007 Apr; 56(Pt 4):454-458. PubMed ID: 17374883
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis.
Hernandez Pando R; Aguilar LD; Smith I; Manganelli R
Infect Immun; 2010 Jul; 78(7):3168-76. PubMed ID: 20457786
[TBL] [Abstract][Full Text] [Related]
8. Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice.
Solans L; Uranga S; Aguilo N; Arnal C; Gomez AB; Monzon M; Badiola JJ; Gicquel B; Martin C
Vaccine; 2014 Sep; 32(40):5192-7. PubMed ID: 25066740
[TBL] [Abstract][Full Text] [Related]
9. Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate.
Sampson SL; Mansfield KG; Carville A; Magee DM; Quitugua T; Howerth EW; Bloom BR; Hondalus MK
Vaccine; 2011 Jun; 29(29-30):4839-47. PubMed ID: 21549795
[TBL] [Abstract][Full Text] [Related]
10. Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis.
Levillain F; Kim H; Woong Kwon K; Clark S; Cia F; Malaga W; Lanni F; Brodin P; Gicquel B; Guilhot C; Bancroft GJ; Williams A; Jae Shin S; Poquet Y; Neyrolles O
Vaccine; 2020 Feb; 38(6):1416-1423. PubMed ID: 31862194
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant.
Infante E; Aguilar LD; Gicquel B; Pando RH
Clin Exp Immunol; 2005 Jul; 141(1):21-8. PubMed ID: 15958066
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis virulence: insights and impact on vaccine development.
Delogu G; Provvedi R; Sali M; Manganelli R
Future Microbiol; 2015; 10(7):1177-94. PubMed ID: 26119086
[TBL] [Abstract][Full Text] [Related]
13. Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.
Marcus SA; Steinberg H; Talaat AM
Vaccine; 2015 Oct; 33(42):5633-5639. PubMed ID: 26363381
[TBL] [Abstract][Full Text] [Related]
14. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis requires the ECF sigma factor SigE to arrest phagosome maturation.
Casonato S; Provvedi R; Dainese E; Palù G; Manganelli R
PLoS One; 2014; 9(9):e108893. PubMed ID: 25268826
[TBL] [Abstract][Full Text] [Related]
16. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs.
Sakthi S; Palaniyandi K; Gupta UD; Gupta P; Narayanan S
Vaccine; 2016 Feb; 34(6):735-43. PubMed ID: 26768127
[TBL] [Abstract][Full Text] [Related]
18. Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.
Sander P; Clark S; Petrera A; Vilaplana C; Meuli M; Selchow P; Zelmer A; Mohanan D; Andreu N; Rayner E; Dal Molin M; Bancroft GJ; Johansen P; Cardona PJ; Williams A; Böttger EC
Vaccine; 2015 Mar; 33(11):1353-9. PubMed ID: 25657094
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.
Sambandamurthy VK; Derrick SC; Hsu T; Chen B; Larsen MH; Jalapathy KV; Chen M; Kim J; Porcelli SA; Chan J; Morris SL; Jacobs WR
Vaccine; 2006 Sep; 24(37-39):6309-20. PubMed ID: 16860907
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis.
Aguilar LD; Infante E; Bianco MV; Cataldi A; Bigi F; Pando RH
Vaccine; 2006 Mar; 24(13):2333-42. PubMed ID: 16388878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
